Healthleap, which makes AI screening software to identify patients at risk of undiagnosed illnesses, raised $38M across a $30M Series A and an $8M seed (Ram Iyer/TechCrunch)

Healthleap’s $38 million raise signals continued investor confidence in AI-driven healthcare tools that can mine patient records to find undiagnosed conditions earlier, with the potential to improve care outcomes and reduce expensive downstream treatment. For CIOs and technology leaders in healthcare, this underscores the growing strategic importance of AI screening capabilities, but also the need to validate clinical accuracy, integrate securely with existing systems, and manage privacy, compliance, and workflow adoption.